Outpatient Therapy denied as experimental or investigational by Aetna?

Aetna's specific coverage criteria for outpatient therapy are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Aetna Denied Outpatient Therapy as Experimental

An experimental or investigational denial from Aetna means the plan concluded that the specific therapy modality, protocol, or technology lacks sufficient evidence of clinical effectiveness under Aetna's evidence-review standards. This label is applied more broadly than most patients expect — it can cover established therapies when delivered for a specific indication Aetna has not yet endorsed, or newer evidence-based modalities that have not yet been incorporated into Aetna's clinical policy bulletins.

## Why This Denial Is Appealable

Professional societies — including the American Psychological Association, the American Physical Therapy Association, the American Occupational Therapy Association, and specialty-specific bodies depending on the type of therapy — regularly publish clinical practice guidelines and position statements supporting evidence-based outpatient therapy. If your treatment is consistent with recognized guidelines, that misalignment between Aetna's policy and mainstream clinical standards is the central argument for reversal.

## Federal Appeal Framework

• ACA §2719 External Review: Non-grandfathered plans must offer external review by an Independent Review Organization (IRO). Experimental/investigational denials are specifically eligible for IRO review in most states. The external-review request deadline is typically around four months from the denial — confirm the exact date on your EOB.
• ERISA §503: The plan must disclose the specific evidence-review criteria and sources used to classify your therapy as experimental. You are entitled to those documents and can challenge the classification.
• Expedited review: Available if a delay would seriously jeopardize your health.

## Appeal Timeline

1. Request the complete denial file from Aetna, including the clinical policy bulletin and any peer-reviewed sources cited. 2. File your internal appeal with a rebuttal supported by published guidelines. 3. If denied internally, submit to external review before the deadline.

## Documentation to Gather

• Diagnosis and functional-status records: Current chart notes establishing the condition and its severity.
• Treating clinician letter: A narrative explaining the evidence basis for the recommended therapy, referencing the applicable professional-society guideline by name and organization (without citing specific statistics).
• Literature support: Peer-reviewed publications and guideline statements your clinician selects to demonstrate clinical acceptance — your provider's office can compile these.
• Prior-treatment history: Records of other treatments attempted, with dates and outcomes, showing why this modality is the appropriate next step.

## Criteria-Mapping Structure

Obtain Aetna's clinical policy bulletin for the specific therapy type and map each evidentiary criterion:

| Aetna Evidentiary Criterion | Your Rebuttal Evidence | |---|---| | Published peer-reviewed support required | Attach guideline organization citation and relevant literature | | Not classified as experimental by recognized bodies | Reference applicable professional society position | | Consistent with generally accepted standards of practice | Treating clinician attestation + chart documentation |